HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Atsushi Okumura Selected Research
Atsushi Okumura Research Topics
Disease
22
Infections
01/2023 - 09/2007
19
COVID-19
01/2023 - 01/2020
10
Pneumonia (Pneumonitis)
01/2022 - 08/2014
5
Vesicular Stomatitis
01/2023 - 09/2007
3
Disease Progression
01/2023 - 08/2022
3
Virus Diseases (Viral Diseases)
01/2021 - 03/2008
2
Henipavirus Infections
01/2023 - 01/2023
2
Lung Diseases (Lung Disease)
02/2022 - 01/2022
2
Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 01/2022
2
Respiratory Tract Diseases (Respiratory Tract Disease)
01/2022 - 04/2020
2
Neoplasms (Cancer)
01/2016 - 01/2010
2
Shock
10/2015 - 01/2010
2
Ebola Hemorrhagic Fever
10/2015 - 01/2010
1
Pulmonary Edema
01/2022
1
Hyperplasia
01/2022
1
Asymptomatic Infections
12/2021
1
Crimean Hemorrhagic Fever
01/2021
1
Animal Disease Models
12/2020
1
Orthomyxoviridae Infections
02/2020
1
Coronavirus Infections
01/2020
1
Severe Acute Respiratory Syndrome
01/2020
1
Protein-Losing Enteropathies (Protein-Losing Enteropathy)
05/2018
1
Leukemia
01/2016
1
Lassa Fever (Fever, Lassa)
10/2015
1
Human Influenza (Influenza)
10/2015
1
Mesothelioma
01/2010
1
Malignant Mesothelioma
01/2010
Drug/Important Bio-Agent (IBA)
15
Vaccines
IBA
01/2023 - 09/2007
8
Antiviral Agents (Antivirals)
IBA
01/2022 - 03/2008
6
molnupiravir
IBA
01/2023 - 10/2020
5
remdesivir
IBA
01/2023 - 01/2020
5
Proteins (Proteins, Gene)
FDA Link
01/2016 - 09/2007
4
Nucleosides
IBA
01/2023 - 01/2022
4
ChAdOx1 nCoV-19
IBA
02/2021 - 05/2020
4
Cytokines
IBA
10/2015 - 01/2010
3
Neutralizing Antibodies
IBA
01/2023 - 01/2021
2
nirmatrelvir
IBA
01/2023 - 09/2022
2
Protease Inhibitors (Protease Inhibitor)
IBA
01/2023 - 09/2022
2
N-methyl-valyl-amiclenomycin (BA 2)
IBA
11/2022 - 08/2022
2
N-(2-cyanoethylene)urea (BA 1)
IBA
11/2022 - 08/2022
2
Viral Antigens
IBA
02/2022 - 01/2022
2
Glycoproteins (Glycoprotein)
IBA
01/2022 - 01/2021
2
SARS-CoV-2 spike protein
IBA
01/2022 - 01/2021
2
Hydroxychloroquine (Plaquenil)
FDA Link
Generic
12/2020 - 06/2020
2
Ribavirin (Virazole)
FDA Link
Generic
10/2015 - 10/2013
2
Chemokines
IBA
08/2014 - 10/2013
1
ProTides
IBA
01/2023
1
Fibrin
IBA
01/2022
1
Reston
IBA
12/2021
1
Synthetic Vaccines (Recombinant Vaccines)
IBA
01/2021
1
RNA (Ribonucleic Acid)
IBA
01/2021
1
A-Form DNA (A-DNA)
IBA
01/2021
1
Antibodies
IBA
01/2021
1
Pasteurella multocida toxin
IBA
02/2020
1
Nucleotides
IBA
01/2020
1
Prodrugs
IBA
01/2020
1
N-Acetylneuraminic Acid (Sialic Acid)
IBA
01/2016
1
Epitopes
IBA
01/2016
1
Neuraminidase (Sialidase)
IBA
01/2016
1
Monoclonal Antibodies
IBA
01/2016
1
Antigens
IBA
01/2016
1
favipiravir
IBA
10/2015
1
Double-Stranded RNA (RNA, Double Stranded)
IBA
01/2010
1
Interferons
IBA
01/2010
1
Interferon-beta
IBA
01/2010
1
eIF-2 Kinase (eIF 2 Kinase)
IBA
01/2010
1
Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)
IBA
01/2010
1
Messenger RNA (mRNA)
IBA
01/2010
1
Ubiquitin
IBA
03/2008
1
Ubiquitins
IBA
03/2008
1
Matrix-M
IBA
09/2007
Therapy/Procedure
4
Therapeutics
04/2020 - 08/2014
1
Aftercare (After-Treatment)
05/2018
1
Immunotherapy
01/2016
1
Euthanasia (Mercy Killing)
08/2014
1
Oncolytic Virotherapy
01/2010